LSBio The Immunohistochemistry Antibody Company
  • Antibodies
    • All Antibodies
    • Primary Antibodies
    • Secondary Antibodies
    • IHC-plus Antibodies
    • Isotype Control Antibodies
    • Blocking Peptides
  • ELISA Kits
    • All Kits
    • Sandwich ELISA Kits
    • EIA Kits
    • Cell-Based ELISA Kits
    • DNA-Binding ELISA Kits
    • Direct ELISA Kits
    • Functional ELISA Kits
    • Phospho-Specific ELISA Kits
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Resources
    • About LifeSpan
    • About our Tissue Bank
    • IHC-plus Protocol
    • Rewards Program
    • Publications
    • Secure FTP Login
    • IHC Database Login
  • Contact Us
    • Contact Us
    • Customer Support
    • Distributor List
    • How to Buy
    • Holiday Schedule
  • Quick Order ▾
  • View Cart

Anti-GM2A Antibody LS-C189990

See our new GM2A ELISA Kits
Human GM2A ELISA Kit - LS-F6859
(kits do not necessarily contain the antibody listed on this page)

Ordering

Wt. Vol. Conc. Price
50 µg - - $425

LSBio (Direct) LSBio (Direct)
206-374-1102
866-206-6909
Orders@LSBio.com
 

100% Guaranteed 100% Guaranteed
Rabbit Polyclonal (IgG) to Human GM2A
Human
Western blot, ELISA
Unconjugated

Details

Human GM2A
Rabbit
Human (tested or 100% immunogen sequence identity)
IgG Polyclonal
Purified

Applications

Western blot, ELISA

Specificity and Use

GM2A antibody was raised against recombinant corresponding to human Ganglioside GM2 activator.
Human GM2A.

Packaging

PBS
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at 12 months.
For research use only.

About GM2A

P17900 NM_000405 NP_000396.2

GM2A Antibody, Ganglioside GM2 activator Antibody, GM2 ganglioside activator Antibody, GM2-AP Antibody, SAP-3 Antibody

The protein encoded by this gene is a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme, beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease.

Requested From: United States
Date Requested: 4/18/2015

Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn
Copyright © 2015 LifeSpan BioSciences, Inc. All Rights Reserved Privacy Policy
Catalog Number